Indegene, 544172, INDGN Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

14,104.09
32.39
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

13,729.49
0.34%
5.23

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

23.51
24.06
7.18

EBITDA CAGR (%)

10 Years
5 Years
3 Years

26.12
18.31
6.18

PAT CAGR (%)

10 Years
5 Years
3 Years

27.64
16.98
15.19

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 15.19 17.15 19.81 23.19
P/E Ratio 38.68 34.26 29.66 25.34
Revenue 2590 2839 3193 3627
EBITDA 505 534 632 724
Net Income 337 407 477 558
ROA 14.2 13.9 13.9 15.4
P/B Ratio 13.68 5.38 4.63 3.97
ROE 27.01 20.11 17.1 17.19
FCFF 319 339 436 507
FCFF Yield 2.55 2.7 3.48 4.04
Net Debt -498 -1563 -1540 -1788
BVPS 42.95 109.21 126.9 148.03

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 255.60 258.60 -1.16% 266.70 272.50 -2.13% 286.70 260.00 10.27% 281.70 260.50 8.14%
Expenses 218.90 219.10 -0.09% 227.10 226.10 0.44% 234.80 223.00 5.29% 235.30 217.10 8.38%
EBITDA 36.70 39.50 -7.09% 39.60 46.40 -14.66% 51.90 37.00 40.27% 46.40 43.40 6.91%
EBIDTM 14.36% 15.27% 14.85% 17.03% 18.10% 14.23% 16.47% 16.66%
Other Income 32.10 13.70 134.31% 35.20 23.10 52.38% 22.30 12.00 85.83% 22.40 6.00 273.33%
Interest 1.70 1.50 13.33% 1.50 1.50 0.00% 1.60 1.70 -5.88% 1.60 1.70 -5.88%
Depreciation 7.30 6.60 10.61% 6.90 7.60 -9.21% 6.50 6.50 0.00% 6.20 8.30 -25.30%
PBT 59.80 45.10 32.59% 66.40 60.40 9.93% 66.10 40.80 62.01% 61.00 39.40 54.82%
Tax 14.70 12.50 17.60% 12.20 11.50 6.09% 16.20 11.20 44.64% 16.20 10.10 60.40%
PAT 45.10 32.60 38.34% 54.20 48.90 10.84% 49.90 29.60 68.58% 44.80 29.30 52.90%
PATM 17.64% 12.61% 20.32% 17.95% 17.41% 11.38% 15.90% 11.25%
EPS 1.88 1.36 38.24% 2.26 2.04 10.78% 2.08 1.23 69.11% 1.87 1.22 53.28%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 760.80 676.50 12.46% 755.60 673.00 12.27% 720.40 673.40 6.98% 686.80 635.70 8.04%
Expenses 605.50 547.60 10.57% 608.10 534.30 13.81% 588.60 524.50 12.22% 560.70 514.60 8.96%
EBITDA 155.30 128.90 20.48% 147.50 138.70 6.34% 131.80 148.90 -11.48% 126.10 121.10 4.13%
EBIDTM 20.41% 19.05% 19.52% 20.61% 18.30% 22.11% 18.36% 19.05%
Other Income 22.10 22.50 -1.78% 25.60 23.20 10.34% 37.70 13.10 187.79% 21.40 11.60 84.48%
Interest 3.70 11.70 -68.38% 3.10 12.30 -74.80% 3.20 12.10 -73.55% 4.00 12.30 -67.48%
Depreciation 21.60 20.10 7.46% 20.70 18.50 11.89% 20.00 17.60 13.64% 19.40 19.80 -2.02%
PBT 152.10 119.60 27.17% 149.30 133.50 11.84% 146.30 132.30 10.58% 124.10 100.60 23.36%
Tax 35.70 31.90 11.91% 31.70 38.70 -18.09% 36.60 33.50 9.25% 32.40 25.60 26.56%
PAT 116.40 87.70 32.73% 117.60 94.80 24.05% 109.70 98.80 11.03% 91.70 75.00 22.27%
PATM 15.30% 12.96% 15.56% 14.09% 15.23% 14.67% 13.35% 11.80%
EPS 4.86 3.66 32.79% 4.91 4.27 14.99% 4.59 4.45 3.15% 3.84 3.39 13.27%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 1,090.70 1,093.60 1,045.60 1,005.70 836.70 511.00 192.28 154.00 109.00 89.22 83.13 Net Sales Growth 3.72% 4.59% 3.97% 20.20% 63.74% 165.76% 24.86% 41.28% 22.17% 7.33% Cost Of Goods Sold 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 1,090.70 1,093.60 1,045.60 1,005.70 836.70 511.00 192.28 154.00 109.00 89.22 83.13 GP Margin 100.00% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 916.10 913.10 877.60 828.10 668.00 361.00 159.58 130.68 99.46 79.82 68.78 Power & Fuel Cost - 0.00 0.00 0.00 1.10 1.00 1.26 0.96 1.03 0.00 0.00 % Of Sales - 0% 0% 0% 0.13% 0.20% 0.66% 0.62% 0.94% 0% 0% Employee Cost - 759.20 752.30 701.20 526.00 273.00 108.14 83.64 63.37 0.00 0.00 % Of Sales - 69.42% 71.95% 69.72% 62.87% 53.42% 56.24% 54.31% 58.14% 0% 0% Manufacturing Exp. - 32.90 23.50 36.40 76.20 49.50 15.40 16.72 12.15 0.00 0.00 % Of Sales - 3.01% 2.25% 3.62% 9.11% 9.69% 8.01% 10.86% 11.15% 0% 0% General & Admin Exp. - 112.40 93.30 81.40 58.90 31.40 30.35 27.46 22.74 79.82 68.78 % Of Sales - 10.28% 8.92% 8.09% 7.04% 6.14% 15.78% 17.83% 20.86% 89.46% 82.74% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0.04% 0% 0% Miscellaneous Exp. - 8.60 8.50 9.10 5.80 6.10 4.43 1.90 0.14 0.00 0.00 % Of Sales - 0.79% 0.81% 0.90% 0.69% 1.19% 2.30% 1.23% 0.13% 0% 0% EBITDA 174.60 180.50 168.00 177.60 168.70 150.00 32.70 23.32 9.54 9.40 14.35 EBITDA Margin 16.01% 16.51% 16.07% 17.66% 20.16% 29.35% 17.01% 15.14% 8.75% 10.54% 17.26% Other Income 112.00 90.40 50.30 37.10 27.80 24.50 3.11 8.28 7.50 4.60 0.00 Interest 6.40 6.20 6.60 6.40 3.00 3.50 1.42 0.51 0.63 0.66 2.14 Depreciation 26.90 26.20 31.10 31.70 23.60 17.60 3.56 3.23 2.62 3.06 2.32 PBT 253.30 238.50 180.60 176.60 169.90 153.40 30.82 27.85 13.79 10.28 9.90 Tax 59.30 57.20 42.70 46.40 37.20 26.90 1.24 -0.65 2.29 2.61 3.30 Tax Rate 23.41% 23.98% 23.64% 26.27% 21.90% 17.20% 4.02% -2.33% 16.61% 25.39% 33.33% PAT 194.00 181.30 137.90 130.20 132.70 129.50 29.58 28.50 11.50 7.67 6.60 PAT before Minority Interest 194.00 181.30 137.90 130.20 132.70 129.50 29.58 28.50 11.50 7.67 6.60 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 17.79% 16.58% 13.19% 12.95% 15.86% 25.34% 15.38% 18.51% 10.55% 8.60% 7.94% PAT Growth 38.18% 31.47% 5.91% -1.88% 2.47% 337.80% 3.79% 147.83% 49.93% 16.21% EPS 8.08 7.55 5.74 5.42 5.53 5.39 1.23 1.19 0.48 0.32 0.27

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 17 Mar 16 Mar 15
Net Sales 2,923.60 2,839.30 2,589.60 2,306.10 1,664.61 966.27 472.06 343.75 233.52 Net Sales Growth 9.97% 9.64% 12.29% 38.54% 72.27% 104.69% 37.33% 47.20% Cost Of Goods Sold 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 2,923.60 2,839.30 2,589.60 2,306.10 1,664.61 966.27 472.06 343.75 233.52 GP Margin 100.00% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 2,362.90 2,305.00 2,084.20 1,910.20 1,377.69 735.74 401.24 291.26 203.85 Power & Fuel Cost - 0.00 0.00 0.00 0.00 0.00 1.51 1.00 1.09 % Of Sales - 0% 0% 0% 0% 0% 0.32% 0.29% 0.47% Employee Cost - 1,815.20 1,651.60 1,464.80 1,014.34 535.60 265.21 183.32 103.55 % Of Sales - 63.93% 63.78% 63.52% 60.94% 55.43% 56.18% 53.33% 44.34% Manufacturing Exp. - 171.80 168.10 200.60 214.41 119.40 45.53 43.22 54.63 % Of Sales - 6.05% 6.49% 8.70% 12.88% 12.36% 9.64% 12.57% 23.39% General & Admin Exp. - 271.90 242.80 223.50 137.04 74.79 85.37 58.76 43.07 % Of Sales - 9.58% 9.38% 9.69% 8.23% 7.74% 18.08% 17.09% 18.44% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.09 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0.47% Miscellaneous Exp. - 46.10 21.70 21.30 11.89 5.96 3.62 4.97 0.42 % Of Sales - 1.62% 0.84% 0.92% 0.71% 0.62% 0.77% 1.45% 0.18% EBITDA 560.70 534.30 505.40 395.90 286.92 230.53 70.82 52.49 29.67 EBITDA Margin 19.18% 18.82% 19.52% 17.17% 17.24% 23.86% 15.00% 15.27% 12.71% Other Income 106.80 107.20 76.30 58.20 25.89 30.65 0.24 3.50 3.97 Interest 14.00 22.00 49.40 31.30 5.96 6.96 9.66 2.46 2.37 Depreciation 81.70 80.20 76.10 59.80 33.45 25.55 19.12 15.19 7.46 PBT 571.80 539.30 456.20 363.00 273.39 228.67 42.28 38.34 23.81 Tax 136.40 132.60 121.90 96.90 63.68 45.78 3.20 2.91 5.48 Tax Rate 23.85% 24.59% 26.58% 26.69% 28.12% 19.76% 7.57% 7.59% 23.02% PAT 435.40 406.70 336.70 266.10 164.76 185.67 39.08 35.43 18.33 PAT before Minority Interest 435.40 406.70 336.70 266.10 162.82 185.68 39.08 35.43 18.33 Minority Interest 0.00 0.00 0.00 0.00 1.94 -0.01 0.00 0.00 0.00 PAT Margin 14.89% 14.32% 13.00% 11.54% 9.90% 19.22% 8.28% 10.31% 7.85% PAT Growth 22.20% 20.79% 26.53% 61.51% -11.26% 375.10% 10.30% 93.29% EPS 18.13 16.94 14.02 11.08 6.86 7.73 1.63 1.48 0.76

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 1,888.20 953.80 795.30 650.00 253.90 118.49 110.76 97.33 90.29 85.89 Share Capital 47.90 44.40 44.30 0.40 0.30 78.87 72.00 72.00 72.00 64.57 Total Reserves 1,804.10 878.00 733.20 643.80 249.20 38.85 31.18 24.39 18.29 13.89 Non-Current Liabilities 50.40 53.20 59.40 48.80 7.10 2.21 2.16 1.58 0.00 1.62 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.58 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 Long Term Provisions 58.50 43.20 35.00 26.50 13.20 2.62 2.36 1.74 0.00 0.00 Current Liabilities 189.50 198.10 169.40 140.70 93.30 42.12 30.28 18.78 14.01 9.76 Trade Payables 34.80 57.30 24.50 25.80 42.80 7.96 5.47 4.20 0.55 0.93 Other Current Liabilities 106.70 96.80 104.70 91.50 33.30 13.56 12.78 10.77 10.52 7.10 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 12.34 4.81 0.00 0.00 0.00 Short Term Provisions 48.00 44.00 40.20 23.40 17.20 8.26 7.21 3.82 2.94 1.73 Total Liabilities 2,128.10 1,205.10 1,024.10 839.50 354.30 162.82 143.20 117.69 104.30 97.27 Net Block 52.80 56.10 78.30 72.00 40.60 8.44 9.72 2.68 2.47 2.22 Gross Block 183.20 175.20 187.40 149.40 99.40 18.99 17.21 7.85 6.37 5.05 Accumulated Depreciation 130.40 119.10 109.10 77.40 58.80 10.55 7.49 5.17 3.90 2.83 Non Current Assets 910.10 454.10 321.20 305.00 136.40 129.60 101.57 80.82 62.25 57.74 Capital Work in Progress 3.60 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 471.30 385.40 231.50 83.40 83.40 77.02 62.21 59.98 59.78 55.52 Long Term Loans & Adv. 382.00 12.50 11.10 149.50 12.30 36.44 23.58 13.81 0.00 0.00 Other Non Current Assets 0.40 0.10 0.30 0.10 0.10 7.71 6.07 4.35 0.00 0.00 Current Assets 1,218.00 751.00 702.90 534.50 217.90 33.22 41.63 36.87 42.05 39.53 Current Investments 503.30 238.40 168.80 119.90 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 418.40 378.00 400.80 349.50 175.10 15.76 26.21 18.35 21.20 15.81 Cash & Bank 163.60 15.60 54.00 38.80 18.20 4.21 2.70 6.23 3.78 5.31 Other Current Assets 132.70 100.40 62.00 24.30 24.60 13.26 12.73 12.28 17.07 18.41 Short Term Loans & Adv. 70.80 18.60 17.30 2.00 3.10 10.51 0.92 0.91 16.25 17.99 Net Current Assets 1,028.50 552.90 533.50 393.80 124.60 -8.90 11.35 18.09 28.04 29.76 Total Assets 2,128.10 1,205.10 1,024.10 839.50 354.30 162.82 143.20 117.69 104.30 97.27

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 2,615.60 1,429.10 1,063.80 763.90 324.51 Share Capital 47.90 44.40 44.30 0.35 0.31 Total Reserves 2,531.60 1,353.30 1,001.70 757.79 319.79 Non-Current Liabilities 56.00 434.80 583.90 79.97 26.79 Secured Loans 0.00 333.40 394.30 10.94 17.69 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 58.50 43.20 35.00 26.47 12.30 Current Liabilities 564.50 610.90 489.10 440.44 199.43 Trade Payables 93.40 118.10 73.30 74.22 50.19 Other Current Liabilities 395.30 402.50 354.30 305.48 128.39 Short Term Borrowings 0.00 9.70 0.00 0.00 0.00 Short Term Provisions 75.80 80.60 61.50 60.74 20.84 Total Liabilities 3,236.10 2,474.80 2,136.80 1,284.31 559.30 Net Block 677.60 645.80 664.10 137.72 85.92 Gross Block 1,095.50 995.10 863.40 271.29 191.10 Accumulated Depreciation 417.90 349.30 199.30 133.56 105.19 Non Current Assets 706.10 684.00 688.10 154.29 100.01 Capital Work in Progress 3.60 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 22.40 35.00 20.30 16.48 14.03 Other Non Current Assets 2.50 3.20 3.70 0.08 0.06 Current Assets 2,530.00 1,790.80 1,448.70 1,130.03 459.29 Current Investments 1,289.70 796.50 614.00 119.86 0.00 Inventories 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 751.40 648.00 642.00 443.91 285.40 Cash & Bank 374.60 191.00 85.80 517.30 139.90 Other Current Assets 114.30 121.40 70.70 42.49 33.99 Short Term Loans & Adv. 60.10 33.90 36.20 6.46 0.65 Net Current Assets 1,965.50 1,179.90 959.60 689.59 259.87 Total Assets 3,236.10 2,474.80 2,136.80 1,284.32 559.30

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 14
Cash From Operating Activity 129.00 176.20 81.90 38.20 53.30 23.83 PBT 238.50 180.60 176.60 169.90 159.90 10.28 Adjustment -40.30 2.50 32.80 15.50 11.30 3.12 Changes in Working Capital 1.40 42.40 -85.70 -111.30 -92.30 13.25 Cash after chg. in Working capital 199.60 225.50 123.70 74.10 78.90 26.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -70.60 -49.30 -41.80 -35.90 -25.60 -2.81 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -824.70 -187.70 -47.90 -266.70 -33.20 -29.85 Net Fixed Assets -11.60 12.20 -38.00 -50.00 -80.41 Net Investments -350.80 -223.50 -197.00 -119.90 -6.38 Others -462.30 23.60 187.10 -96.80 53.59 Cash from Financing Activity 717.30 -15.80 -16.90 244.90 -37.10 7.52 Net Cash Inflow / Outflow 21.60 -27.30 17.10 16.40 -17.00 1.51 Opening Cash & Equivalents 13.20 41.80 27.80 11.60 29.50 2.70 Closing Cash & Equivalent 35.20 13.20 41.80 27.80 11.60 4.21

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 441.90 507.70 130.20 297.04 172.03 PBT 539.30 458.60 363.00 226.50 195.85 Adjustment 38.50 78.20 91.40 87.07 17.29 Changes in Working Capital 24.10 95.80 -216.00 53.82 8.51 Cash after chg. in Working capital 601.90 632.60 238.40 367.39 221.64 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -160.00 -124.90 -108.20 -70.35 -49.61 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -682.70 -327.20 -893.30 -160.21 -24.25 Net Fixed Assets -11.60 12.20 -38.00 -50.00 Net Investments -350.80 -223.50 -197.00 -119.90 Others -320.30 -115.90 -658.30 9.69 Cash from Financing Activity 287.50 -66.20 333.10 233.48 -131.51 Net Cash Inflow / Outflow 46.70 114.30 -430.00 370.31 16.28 Opening Cash & Equivalents 188.60 73.60 506.30 133.36 173.86 Closing Cash & Equivalent 241.00 188.60 73.60 506.28 133.36

Financial Ratios

Standalone /

Consolidated

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 77.33 41.55 35.10 25.56 13.20 254.06 204.28 166.35 120.78 92.19 ROA 10.88% 12.37% 13.97% 22.23% 33.71% 5.01% 5.06% 5.49% 4.37% 4.02% ROE 13.07% 16.22% 18.32% 29.70% 107.25% 21.51% 23.50% 28.16% 26.85% 30.46% ROCE 17.22% 21.41% 25.32% 38.26% 54.43% 8.88% 11.31% 8.43% 6.45% 5.08% Fixed Asset Turnover 6.10 5.77 5.97 6.73 7.27 4.93 6.63 8.48 7.03 7.47 Receivable days 132.90 135.93 136.15 114.43 83.86 85.84 97.82 119.63 168.37 170.55 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 0.00 0.00 802.29 760.90 680.30 168.77 219.24 Cash Conversion Cycle 132.90 135.93 136.15 114.43 83.86 -716.45 -663.08 -560.66 -0.40 -48.69 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.10 0.05 0.00 0.00 0.02 Interest Cover 39.47 28.36 28.59 57.63 45.69 16.66 5.64 7.18 19.86 39.54

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 107.70 62.96 47.22 34.28 16.23 ROA 14.24% 14.60% 15.56% 17.66% 33.13% ROE 20.45% 27.56% 29.50% 30.20% 176.32% ROCE 25.24% 30.88% 35.20% 41.09% 68.54% Fixed Asset Turnover 2.72 2.79 4.06 7.20 4.71 Receivable days 89.95 90.91 85.94 79.96 87.03 Inventory Days 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 0.00 0.00 Cash Conversion Cycle 89.95 90.91 85.94 79.96 87.03 Total Debt/Equity 0.00 0.29 0.38 0.02 0.08 Interest Cover 25.51 10.28 12.60 38.98 34.27

Top Investors:

nadathur fareast pte ltd

manish gupta

rajesh bhaskaran nair

bpc genesis fund i spv ltd

sanjay s parikh

bpc genesis fund i a spv ltd

smallcap world fund, inc

gaurav kapoor

vida trustees private limited

anand kiran

Annual Reports:

News Update:

Indegene launches NEXT Medical Writing Automation
12th Jul 2025, 11:31 AM

It combines Indegene’s decades of domain knowledge with the power of its AI engine, Cortex
Read More
Indegene partners with FAST India to scale up India’s biotech ecosystem
3rd Jul 2025, 14:10 PM

The partnership will focus on expanding research and collaboration between academia and the industry, helping accelerate innovation from the ground up
Read More
Indegene partners with Indian Institute of Cerebral Palsy
19th May 2025, 12:20 PM

The partnership is to enhance the quality of care and bring about a positive change in the lives of people with cerebral palsy
Read More
Indegene partners with Indian School of Public Policy
7th May 2025, 11:07 AM

ISPP will analyze health systems across states, identifying scalable models and actionable insights to strengthen India's healthcare delivery
Read More

Indegene Ltd.

Business Support

BSE: 544172 | NSE: INDGN

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Indegene Ltd.

Business Support

BSE: 544172 | NSE: INDGN

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: